Biotechnology professional with over 15 years of US and Global oncology/hematology experience: provided commercial assessment on numerous in-licensing opportunities, led the successful global launch of a targeted therapy in a major solid tumor and as a Global Commercial Lead, advanced numerous oncology Phase I/II compounds into Phase III registrational trials.
The Financeninvestments (FNI) is a blog aims to present a critical analysis of evolving developments in the financial and investment sector. Written for people with an investment bent of mind, the blog aims to bring forth a compelling commentary on how and why things are evolving the way they are and where it might lead up to.
The objective is to give investment buffs strategic insights into developments that are yet to happen, and arm them with the much needed investment foresight. Whether you agree or disagree with us, we welcome you to exchange ideas with us.